Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

uniQure N.V. (QURE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 SC 13G/A BlackRock Inc. reports a 3.6% stake in uniQure N.V.
10/06/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/06/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
10/05/2023 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "uniQure Announces Strategic Reorganization to Reduce Operating Expenses and Support Advancement of Multiple Clinical-Stage Programs"
08/01/2023 8-K Quarterly results
08/01/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/10/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/16/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "uniQure Announces Sale of Royalty Interest in HEMGENIX for Up To $400 Million"
05/09/2023 8-K Quarterly results
Docs: "uniQure Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress"
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/18/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/27/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "uniQure Announces 2022 Financial Results and Highlights Recent Company Progress"
02/27/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/27/2023 10-K Annual Report for the period ended December 31, 2022
02/14/2023 SC 13G/A Nantahala Capital Management, LLC reports a 8.3% stake in uniQure N.V.
02/14/2023 SC 13G/A PFM Health Sciences, LP reports a 4.9% stake in uniQure N.V.
02/09/2023 SC 13G/A FMR LLC reports a 5.8% stake in UNIQURE N.V.
02/08/2023 SC 13G/A Invesco Ltd. reports a 0.5% stake in uniQure NV
02/03/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/31/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "uniQure and Apic Bio enter into global licensing agreement for APB-102, a clinical stage gene therapy for patients with ALS caused by mutations in SOD1"
12/16/2022 8-K Quarterly results
11/28/2022 8-K Quarterly results
11/23/2022 8-K Quarterly results
11/02/2022 8-K Quarterly results
11/02/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/07/2022 SC 13G/A BlackRock Inc. reports a 10.5% stake in uniQure N.V.
09/26/2022 SC 13G/A Coller International Partners V A LP reports a 0% stake in uniQure N.V.
08/08/2022 8-K Quarterly results
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy